References
- Alam, M. A., and M. M. Rahman. 2014. Mitochondrial dysfunction in obesity: Potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome. Journal of Diabetes and Metabolic Disorders 13 (1):60. doi: https://doi.org/10.1186/2251-6581-13-60.
- Al-Shukaili, A., S. Al-Ghafri, S. Al-Marhoobi, S. Al-Abri, J. Al-Lawati, and M. Al-Maskari. 2013. Analysis of inflammatory mediators in type 2 diabetes patients. International Journal of Endocrinology 2013:976810. doi: https://doi.org/10.1155/2013/976810.
- Alvarez-Guardia, D., X. Palomer, T. Coll, M. M. Davidson, T. O. Chan, A. M. Feldman, J. C. Laguna, and M. Vázquez-Carrera. 2010. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovascular Research 87 (3):449–58. doi: https://doi.org/10.1093/cvr/cvq080.
- Alvarez-Suarez, J. M., F. Giampieri, M. Cordero, M. Gasparrini, T. Y. Forbes-Hernández, L. Mazzoni, S. Afrin, P. Beltrán-Ayala, A. M. González-Paramás, C. Santos-Buelga, et al. 2016. Activation of AMPK/Nrf2 signalling by Manuka honey protects human dermal fibroblasts against oxidative damage by improving antioxidant response and mitochondrial function promoting wound healing. Journal of Functional Foods 25:38–49. doi: https://doi.org/10.1016/j.jff.2016.05.008.
- Andriankaja, O. M., S. P. Barros, K. Moss, F. S. Panagakos, W. DeVizio, J. Beck, and S. Offenbacher. 2009. Levels of serum interleukin (IL)‐6 and gingival crevicular fluid of IL‐1β and prostaglandin E2 among non‐smoking subjects with gingivitis and Type 2 Diabetes. Journal of Periodontology 80 (2):307–16. doi: https://doi.org/10.1902/jop.2009.080385.
- Anoosha, T., and R. Umadevi. 2018. Role of Arjuna bark containing polyherbal formulation on oxidative stress parameters in hyperlipidemic chick model. Journal of Medicinal Plants 6 (5):133–6.
- Antonenko, Y. N., V. A. Roginsky, A. A. Pashkovskaya, T. I. Rokitskaya, E. A. Kotova, A. A. Zaspa, B. V. Chernyak, and V. P. Skulachev. 2008. Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments. The Journal of Membrane Biology 222 (3):141–9. doi: https://doi.org/10.1007/s00232-008-9108-6.
- Ashabi, G., L. Khalaj, F. Khodagholi, M. Goudarzvand, and A. Sarkaki. 2015. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metabolic Brain Disease 30 (3):747–54. doi: https://doi.org/10.1007/s11011-014-9632-2.
- Ashamalla, M., I. Youssef, M. Yacoub, A. Jayarangaiah, N. Gupta, J. Ray, S. Iqbal, R. Miller, J. Singh, and S. I. McFarlane. 2018. Obesity, diabetes and gastrointestinal malignancy: The role of metformin and other anti-diabetic therapy. Global Journal of Obesity, Diabetes and Metabolic Syndrome 5 (2):008–14. doi: https://doi.org/10.17352/2455-8583.000032.
- Asmat, U., K. Abad, and K. Ismail. 2016. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharmaceutical Journal: SPJ: The Official Publication of the Saudi Pharmaceutical Society 24 (5):547–53. doi: https://doi.org/10.1016/j.jsps.2015.03.013.
- Bach, D., D. Naon, S. Pich, F. X. Soriano, N. Vega, J. Rieusset, M. Laville, C. Guillet, Y. Boirie, H. Wallberg-Henriksson, et al. 2005. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: Effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54 (9):2685–93. doi: https://doi.org/10.2337/diabetes.54.9.2685.
- Bach, D., S. Pich, F. X. Soriano, N. Vega, B. Baumgartner, J. Oriola, J. R. Daugaard, J. Lloberas, M. Camps, J. R. Zierath, et al. 2003. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism A novel regulatory mechanism altered in obesity. The Journal of Biological Chemistry 278 (19):17190–7. doi: https://doi.org/10.1074/jbc.M212754200.
- Bajaj, S., and A. Khan. 2012. Antioxidants and diabetes. Indian Journal of Endocrinology and Metabolism 16 (Suppl 2):S267–S271. doi: https://doi.org/10.4103/2230-8210.100673.
- Barouch, L. A., D. Gao, L. Chen, K. L. Miller, W. Xu, A. C. Phan, M. M. Kittleson, K. M. Minhas, D. E. Berkowitz, C. Wei, et al. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circulation Research 98 (1):119–24. doi: https://doi.org/10.1161/01.RES.0000199348.10580.1d.
- Benton, C. R., G. P. Holloway, X. Han, Y. Yoshida, L. A. Snook, J. Lally, J. Glatz, J. Luiken, A. Chabowski, and A. Bonen. 2010. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats . Diabetologia 53 (9):2008–19. doi: https://doi.org/10.1007/s00125-010-1773-1.
- Bhansali, S., A. Bhansali, and V. Dhawan. 2017. Favourable metabolic profile sustains mitophagy and prevents metabolic abnormalities in metabolically healthy obese individuals. Diabetology & Metabolic Syndrome 9 (1):99. doi: https://doi.org/10.1186/s13098-017-0298-x.
- Bhansali, S., A. Bhansali, and V. Dhawan. 2019. Augmented Mitophagy and Inflammasome Activation with Metformin therapy in patients with T2DM. Endocrine Abstracts. doi: https://doi.org/10.1530/endoabs.63.P624.
- Bhatti, J. S., G. K. Bhatti, and P. H. Reddy. 2017. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863 (5):1066–77. doi: https://doi.org/10.1016/j.bbadis.2016.11.010.
- Blasiak, J., M. Arabski, R. Krupa, K. Wozniak, M. Zadrozny, J. Kasznicki, M. Zurawska, and J. Drzewoski. 2004. DNA damage and repair in type 2 diabetes mellitus. Mutation Research 554 (1–2):297–304. doi: https://doi.org/10.1016/j.mrfmmm.2004.05.011.
- Bournat, J. C., and C. W. Brown. 2010. Mitochondrial dysfunction in obesity. Current Opinion in Endocrinology, Diabetes, and Obesity 17 (5):446–52. doi: https://doi.org/10.1097/MED.0b013e32833c3026.
- Brasnyó, P., G. A. Molnár, M. Mohás, L. Markó, B. Laczy, J. Cseh, E. Mikolás, I. A. Szijártó, A. Mérei, R. Halmai, et al. 2011. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. The British Journal of Nutrition 106 (3):383–9. doi: https://doi.org/10.1017/S0007114511000316.
- Bruce, C. R., V. A. Mertz, G. J. Heigenhauser, and D. J. Dyck. 2005. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54 (11):3154–60. doi: https://doi.org/10.2337/diabetes.54.11.3154.
- Butsch, W. S., R. F. Kushner, S. Alford, and B. G. Smolarz. 2020. Low priority of obesity education leads to lack of medical students' preparedness to effectively treat patients with obesity: results from the U.S. medical school obesity education curriculum benchmark study. BMC Medical Education 20 (1):23. doi: https://doi.org/10.1186/s12909-020-1925-z.
- Cao, J., S. Meng, E. Chang, K. Beckwith-Fickas, L. Xiong, R. N. Cole, S. Radovick, F. E. Wondisford, and L. He. 2014. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J. Biol. Chem 289 (30):20435–46. doi: https://doi.org/10.1074/jbc.M114.567271.
- Cash, N. J. 2016. The effects of mitochondria-targeted antioxidant mitoquinone on pancreatic acinar cells. PhD diss., University of Liverpool.
- Chattopadhyay, M., V. K. Khemka, G. Chatterjee, A. Ganguly, S. Mukhopadhyay, and S. Chakrabarti. 2015. Enhanced ROS production and oxidative damage in subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes subjects. Molecular and Cellular Biochemistry 399 (1–2):95–103. doi: https://doi.org/10.1007/s11010-014-2236-7.
- Chen, M., Z. Chen, Y. Wang, Z. Tan, C. Zhu, Y. Li, Z. Han, L. Chen, R. Gao, L. Liu, et al. 2016. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12 (4):689–702. doi: https://doi.org/10.1080/15548627.2016.1151580.
- Choudhury, S., S. Ghosh, P. Gupta, S. Mukherjee, and S. Chattopadhyay. 2015. Inflammation-induced ROS generation causes pancreatic cell death through modulation of Nrf2/NF-κB and SAPK/JNK pathway. Free Radical Research 49 (11):1371–83. doi: https://doi.org/10.3109/10715762.2015.1075016.
- Cieślak, M., A. Wojtczak, and M. Cieślak. 2015. Role of pro-inflammatory cytokines of pancreatic islets and prospects of elaboration of new methods for the diabetes treatment. Acta Biochimica Polonica 62 (1):15–21. doi: https://doi.org/10.18388/abp.2014_853.
- Commodore-Mensah, Y., E. Selvin, J. Aboagye, R. Turkson-Ocran, X. Li, C. D. Himmelfarb, R. S. Ahima, and L. A. Cooper. 2018. Hypertension, overweight/obesity, and diabetes among immigrants in the United States: An analysis of the 2010-2016 National Health Interview Survey. BMC Public Health 18 (1):1–10. doi: https://doi.org/10.1186/s12889-018-5683-3.
- Coudray, C., G. Fouret, K. Lambert, C. Ferreri, J. Rieusset, A. Blachnio-Zabielska, J. Lecomte, R. Ebabe Elle, E. Badia, M. P. Murphy, et al. 2016. A mitochondrial-targeted ubiquinone modulates muscle lipid profile and improves mitochondrial respiration in obesogenic diet-fed rats. The British Journal of Nutrition 115 (7):1155–66. doi: https://doi.org/10.1017/S0007114515005528.
- Daiber, A., J. Kienhoefer, R. Zee, P. Wenzel, V. Ullrich, B. Loo, and M. Bachschmid. 2010. Oxidative Stress in Applied Basic Research and Clinical Practice. Totowa, NJ: Humana Press.
- Das, A., D. Durrant, S. Koka, F. N. Salloum, L. Xi, and R. C. Kukreja. 2014. mTOR inhibition with rapamycin improves cardiac function in type 2 diabetic mice: Potential role of attenuated oxidative stress and altered contractile protein expression. The Journal of Biological Chemistry 289 (7):4145–60. doi: https://doi.org/10.1074/jbc.M113.521062.
- Das, A., D. Durrant, S. Koka, F. N. Salloum, L. Xi, and R. C. Kukreja. 2014. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. The Journal of Biological Chemistry 289 (7):4145–60. doi: https://doi.org/10.1074/jbc.M113.521062.
- Deedwania, P. C. 2003. Mechanisms of endothelial dysfunction in the metabolic syndrome. Current Diabetes Reports 3 (4):289–92. doi: https://doi.org/10.1007/s11892-003-0019-8.
- Deng, X., G. Yang, X. Zheng, Y. Yang, H. Qin, Z. X. Liu, H. Deng, and S. M. Liu. 2019. Plasma mtDNA copy numbers are associated with GSTK1 expression and inflammation in type 2 diabetes. Diabetic Medicine 0:1–5. doi: https://doi.org/10.1111/dme.14132.
- Desta, Y. T., M. Wu, L. Bai, X. Wu, M. Xiong, and X. Weng. 2020. Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation. International Immunopharmacology 84:106518. doi: https://doi.org/10.1016/j.intimp.2020.106518.
- Di Sante, G., T. G. Pestell, M. C. Casimiro, S. Bisetto, M. J. Powell, M. P. Lisanti, C. Cordon-Cardo, M. Castillo-Martin, D. M. Bonal, V. Debattisti, et al. 2015. Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria. The American Journal of Pathology 185 (1):266–79. doi: https://doi.org/10.1016/j.ajpath.2014.09.014.
- Ding, M., C. Liu, R. Shi, M. Yu, K. Zeng, J. Kang, F. Fu, and M. Mi. 2020. Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1-dependent way. Acta Physiologica (Oxford, England) 229 (1):e13428. doi: https://doi.org/10.1111/apha.13428.
- Dodson, M., and D. Zhang. 2016. Chronic arsenic-induced metabolic syndrome: A role for prolonged Nrf2 activation and mitochondrial metabolism. Free Radical Biology and Medicine 100:S183. doi: https://doi.org/10.1016/j.freeradbiomed.2016.10.482.
- Dong, F., Q. Li, N. Sreejayan, J. M. Nunn, and J. Ren. 2007. Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes 56 (9):2201–12. doi: https://doi.org/10.2337/db06-1596.
- Drew, B. G., S. T. Bond, A. C. Calkin, and J. Kim. 2019. The antioxidant moiety of MitoQ imparts minimal metabolic effects in adipose tissue of high fat fed mice. Frontiers in Physiology 10:543. doi: https://doi.org/10.3389/fphys.2019.00543.
- Elmarakby, A. A., and J. D. Imig. 2010. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive e rats. Clinical Science 118 (4):291–301. doi: https://doi.org/10.1042/CS20090395.
- Emamalipour, M., K. Seidi, A. J. Esfahlan, and R. Jahanban Esfahlan. 2019. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines. Journal of Cellular Physiology 234 (12):21758–69. doi: https://doi.org/10.1002/jcp.28913.
- Escribano-Lopez, I., C. Bañuls, N. Diaz-Morales, F. Iannantuoni, S. Rovira-Llopis, R. Gomis, M. Rocha, A. Hernandez-Mijares, M. P. Murphy, and V. M. Victor. 2019. The mitochondria-targeted antioxidant mitoq modulates mitochondrial function and endoplasmic reticulum stress in pancreatic ß cells exposed to hyperglycaemia. Cellular Physiology and Biochemistry 52:186–97.
- Escribano-Lopez, I., N. Diaz-Morales, F. Iannantuoni, S. Lopez-Domenech, A. M. de Marañon, Z. Abad-Jimenez, C. Bañuls, S. Rovira-Llopis, J. R. Herance, M. Rocha, et al. 2018. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes. Scientific Reports 8 (1):1–10. doi: https://doi.org/10.1038/s41598-018-34251-8.
- Escribano-Lopez, I., N. Diaz-Morales, S. Rovira-Llopis, A. M. de Marañon, S. Orden, A. Alvarez, C. Bañuls, M. Rocha, M. P. Murphy, A. Hernandez-Mijares, et al. 2016. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients. Redox Biology 10:200–5. doi: https://doi.org/10.1016/j.redox.2016.10.017.
- Espach, Y., A. Lochner, H. Strijdom, and B. Huisamen. 2015. ATM protein kinase signaling, type 2 diabetes and cardiovascular disease. Cardiovascular Drugs and Therapy 29 (1):51–8. doi: https://doi.org/10.1007/s10557-015-6571-z.
- Fathy, S. A., M. R. Mohamed, M. A. Ali, A. E. EL-Helaly, and A. T. Alattar. 2019. Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 24 (1):43–55. doi: https://doi.org/10.1080/1354750X.2018.1501761.
- Federico, A., F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer 121 (11):2381–6. doi: https://doi.org/10.1002/ijc.23192.
- Feillet-Coudray, C., G. Fouret, R. Ebabe Elle, J. Rieusset, B. Bonafos, B. Chabi, D. Crouzier, K. Zarkovic, N. Zarkovic, J. Ramos, et al. 2014. The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol. Free Radical Research 48 (10):1232–46. doi: https://doi.org/10.3109/10715762.2014.945079.
- Fouret, G., E. Tolika, J. Lecomte, B. Bonafos, M. Aoun, M. P. Murphy, C. Ferreri, C. Chatgilialoglu, E. Dubreucq, C. Coudray, et al. 2015. The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats. Biochimica et Biophysica Acta 1847 (10):1025–35. doi: https://doi.org/10.1016/j.bbabio.2015.05.019.
- Fourny, N., C. Lan, E. Sérée, M. Bernard, and M. Desrois. 2019. Protective effect of resveratrol against ischemia-reperfusion injury via enhanced high energy compounds and eNOS-SIRT1 expression in type 2 diabetic female rat heart. Nutrients 11 (1):105. doi: https://doi.org/10.3390/nu11010105.
- Furukawa, S., T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 114 (12):1752–61. doi: https://doi.org/10.1172/JCI21625.
- Gan, L., Z. Wang, J. Si, R. Zhou, C. Sun, Y. Liu, Y. Ye, Y. Zhang, Z. Liu, and H. Zhang. 2018. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion 56Fe radiation induced brain injury in mice. Toxicology and Applied Pharmacology 341:1–7. doi: https://doi.org/10.1016/j.taap.2018.01.003.
- Geng, T., P. Li, M. Okutsu, X. Yin, J. Kwek, M. Zhang, and Z. Yan. 2010. PGC-1alpha plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle . American Journal of Physiology. Cell Physiology 298 (3):C572–9. doi: https://doi.org/10.1152/ajpcell.00481.2009.
- Goh, K. P., H. Y. Lee, D. P. Lau, W. Supaat, Y. H. Chan, and A. F. Y. Koh. 2014. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. International Journal of Sport Nutrition and Exercise Metabolism 24 (1):2–13. doi: https://doi.org/10.1123/ijsnem.2013-0045.
- Gomes, A. P., F. V. Duarte, P. Nunes, B. P. Hubbard, J. S. Teodoro, A. T. Varela, J. G. Jones, D. A. Sinclair, C. M. Palmeira, and A. P. Rolo. 2012. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochimica et Biophysica Acta 1822 (2):185–95. doi: https://doi.org/10.1016/j.bbadis.2011.10.008.
- Gormand, A., E. Henriksson, K. Ström, T. E. Jensen, K. Sakamoto, and O. Göransson. 2011. Regulation of AMP-activated protein kinase by LKB1 and CaMKK in adipocytes. Journal of Cellular Biochemistry 112 (5):1364–75. doi: https://doi.org/10.1002/jcb.23053.
- Grasemann, H., and F. Holguin. 2020. Oxidative stress and obesity-related asthma. Paediatric Respiratory Reviews doi: https://doi.org/10.1016/j.prrv.2020.05.004.
- Green, D. R., L. Galluzzi, and G. Kroemer. 2011. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (New York, N.Y.) 333 (6046):1109–12. doi: https://doi.org/10.1126/science.1201940.
- Green, C. J., M. Pedersen, B. K. Pedersen, and C. Scheele. 2011. Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase. Diabetes 60 (11):2810–9. doi: https://doi.org/10.2337/db11-0263.
- Guo, R., Y. Zhang, S. Turdi, and J. Ren. 2013. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: Role of autophagy. Biochimica et Biophysica Acta 1832 (8):1136–48. doi: https://doi.org/10.1016/j.bbadis.2013.03.013.
- Halliwell, B., and S. Chirico. 1993. Lipid peroxidation: Its mechanism, measurement, and significance. The American Journal of Clinical Nutrition 57 (5 Suppl):715S–25. doi: https://doi.org/10.1093/ajcn/57.5.715S.
- Han, Y., X. Xu, C. Tang, P. Gao, X. Chen, X. Xiong, M. Yang, S. Yang, X. Zhu, S. Yuan, et al. 2018. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ROS-TXNIP-NLRP3 biological axis. Redox Biology 16:32–46. doi: https://doi.org/10.1016/j.redox.2018.02.013.
- Hao, L., Q. Sun, W. Zhong, W. Zhang, X. Sun, and Z. Zhou. 2018. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease. Redox Biology 14:626–36. doi: https://doi.org/10.1016/j.redox.2017.11.005.
- Hawley, S. A., F. A. Ross, C. Chevtzoff, K. A. Green, A. Evans, S. Fogarty, M. C. Towler, L. J. Brown, O. A. Ogunbayo, A. M. Evans, et al. 2010. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metabolism 11 (6):554–65. doi: https://doi.org/10.1016/j.cmet.2010.04.001.
- Heinonen, S., J. Buzkova, M. Muniandy, R. Kaksonen, M. Ollikainen, K. Ismail, A. Hakkarainen, J. Lundbom, N. Lundbom, K. Vuolteenaho, et al. 2015. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 64 (9):3135–45. doi: https://doi.org/10.2337/db14-1937.
- Hernández, M. G., A. G. Aguilar, J. Burillo, R. G. Oca, M. A. Manca, A. Novials, G. Alcarraz-Vizan, C. Guillén, and M. Benito. 2018. Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics. Cell Death & Disease 9 (5):1–11. doi: https://doi.org/10.1038/s41419-018-0533-x.
- Hirzel, E., P. W. Lindinger, S. Maseneni, M. Giese, V. V. Rhein, A. Eckert, M. Hoch, S. Krähenbühl, and A. N. Eberle. 2013. Differential modulation of ROS signals and other mitochondrial parameters by the antioxidants MitoQ, resveratrol and curcumin in human adipocytes. Journal of Receptor and Signal Transduction Research 33 (5):304–12. doi: https://doi.org/10.3109/10799893.2013.822887.
- Hou, J., Y. Yang, Z. Song, and H. Pei. 2018. GW29-e0076 Tom70 ameliorates cardiac microvascular injury induced by diabetes combined with hyperlipidemia via inhibiting oxidative stress. Journal of the American College of Cardiology 72 (16 Supplement):C2. doi: https://doi.org/10.1016/j.jacc.2018.08.011.
- Huang, C., Y. Zhang, D. J. Kelly, C. Y. R. Tan, A. Gill, D. Cheng, F. Braet, J.-S. Park, C. M. Sue, C. A. Pollock, et al. 2016. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Scientific Reports 6:29196. doi: https://doi.org/10.1038/srep29196.
- Hundal, R. S., M. Krssak, S. Dufour, D. Laurent, V. Lebon, V. Chandramouli, S. E. Inzucchi, W. C. Schumann, K. F. Petersen, B. R. Landau, et al. 2000. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 (12):2063–9. doi: https://doi.org/10.2337/diabetes.49.12.2063.
- Hu, F., X. Qiu, and S. Bu. 2020. Pancreatic islet dysfunction in type 2 diabetes mellitus. Archives of Physiology and Biochemistry 126 (3):235–41. doi: https://doi.org/10.1080/13813455.2018.1510967.
- Hurrle, S., and W. H. Hsu. 2017. The etiology of oxidative stress in insulin resistance. Biomedical Journal 40 (5):257–62. doi: https://doi.org/10.1016/j.bj.2017.06.007.
- Hu, R., H. Yan, X. Hao, H. Liu, and J. Wu. 2013. Shizukaol D isolated from Chloranthus japonicas inhibits AMPK-dependent lipid content in hepatic cells by inducing mitochondrial dysfunction. PloS One 8 (8):e73527. doi: https://doi.org/10.1371/journal.pone.0073527.
- Iwabu, M., T. Yamauchi, M. Okada-Iwabu, K. Sato, T. Nakagawa, M. Funata, M. Yamaguchi, S. Namiki, R. Nakayama, M. Tabata, et al. 2010. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464 (7293):1313–9. doi: https://doi.org/10.1038/nature08991.
- Jain, S. S., S. Paglialunga, C. Vigna, A. Ludzki, E. A. Herbst, J. S. Lally, P. Schrauwen, J. Hoeks, A. R. Tupling, A. Bonen, et al. 2014. High-fat diet-induced mitochondrial biogenesis is regulated by mitochondrial-derived reactive oxygen species activation of CaMKII. Diabetes 63 (6):1907–13. doi: https://doi.org/10.2337/db13-0816.
- James, A. M., M. S. Sharpley, A. B. Manas, F. E. Frerman, J. Hirst, R. A. Smith, and M. P. Murphy. 2007. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. The Journal of Biological Chemistry 282 (20):14708–18. doi: https://doi.org/10.1074/jbc.M611463200.
- Jump, D. B. 2011. Fatty acid regulation of hepatic lipid metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 14 (2):115.
- Jung, M., J. Lee, N. Shin, M. Kim, D. Hyun, J. Yun, P. S. Kim, T. W. Whon, and J. Bae. 2016. Chronic repression of mTOR complex 2 induces changes in the gut microbiota of diet-induced obese mice. Scientific Reports 6 (1):30887–10. doi: https://doi.org/10.1038/srep30887.
- Kahn, B. B., T. Alquier, D. Carling, and D. G. Hardie. 2005. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1 (1):15–25. doi: https://doi.org/10.1016/j.cmet.2004.12.003.
- Kang, C., and L. L. Ji. 2016. PGC-1α overexpression via local transfection attenuates mitophagy pathway in muscle disuse atrophy. Free Radical Biology & Medicine 93:32–40. doi: https://doi.org/10.1016/j.freeradbiomed.2015.12.032.
- Karbownik-Lewinska, M., J. Szosland, A. Kokoszko-Bilska, J. Stępniak, K. Zasada, A. Gesing, and A. Lewinski. 2012. Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinology Letters 33 (4):453–61.
- Keane, K. N., V. F. Cruzat, R. Carlessi, P. I. H. de Bittencourt, and P. Newsholme. 2015. Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxidative Medicine and Cellular Longevity 2015:181643. doi: https://doi.org/10.1155/2015/181643.
- Kelso, G. F., C. M. Porteous, C. V. Coulter, G. Hughes, W. K. Porteous, E. C. Ledgerwood, R. A. Smith, and M. P. Murphy. 2001. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 276 (7):4588–96. doi: https://doi.org/10.1074/jbc.M009093200.
- Khamzina, L., A. Veilleux, S. Bergeron, and A. Marette. 2005. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: Possible involvement in obesity-linked insulin resistance. Endocrinology 146 (3):1473–81. doi: https://doi.org/10.1210/en.2004-0921.
- Khan, T., E. S. Muise, P. Iyengar, Z. V. Wang, M. Chandalia, N. Abate, B. B. Zhang, P. Bonaldo, S. Chua, and P. E. Scherer. 2009. Metabolic dysregulation and adipose tissue fibrosis: Role of collagen VI. Molecular and Cellular Biology 29 (6):1575–91. doi: https://doi.org/10.1128/MCB.01300-08.
- Kim, J.-H., T. G. Choi, S. Park, H. R. Yun, N. N. Y. Nguyen, Y. H. Jo, M. Jang, J. Kim, J. Kim, I. Kang, et al. 2018. Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagy. Cell Death and Differentiation 25 (11):1921–37. doi: https://doi.org/10.1038/s41418-018-0165-9.
- Kim, M. Y., J. H. Lim, H. H. Youn, Y. A. Hong, K. S. Yang, H. S. Park, S. Chung, S. H. Ko, S. H. Koh, S. J. Shin, et al. 2013. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice. Diabetologia 56 (1):204–17. doi: https://doi.org/10.1007/s00125-012-2747-2.
- Kim, J., G. Yang, Y. Kim, J. Kim, and J. Ha. 2016. AMPK activators: Mechanisms of action and physiological activities. Experimental & Molecular Medicine 48 (4):e224. doi: https://doi.org/10.1038/emm.2016.16.
- Kitada, M., A. Takeda, T. Nagai, H. Ito, K. Kanasaki, and D. Koya. 2011. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Experimental Diabetes Research 2011:908185. doi: https://doi.org/10.1155/2011/908185.
- Koka, S., H. S. Aluri, L. Xi, E. J. Lesnefsky, and R. C. Kukreja. 2014. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: Potential role of NO/SIRT1/PGC-1α signaling. The American Journal of Physiology-Heart and Circulatory Physiology 306 (11):H1558–68. doi: https://doi.org/10.1152/ajpheart.00865.2013.
- Kosuru, R., V. Kandula, U. Rai, S. Prakash, Z. Xia, and S. Singh. 2018. Pterostilbene decreases cardiac oxidative stress and inflammation via activation of AMPK/Nrf2/HO-1 pathway in fructose-fed diabetic rats. Cardiovascular Drugs and Therapy 32 (2):147–63. doi: https://doi.org/10.1007/s10557-018-6780-3.
- La Russa, D., F. Giordano, A. Marrone, M. Parafati, E. Janda, and D. Pellegrino. 2019. Oxidative imbalance and kidney damage in cafeteria diet-induced rat model of metabolic syndrome: Effect of bergamot polyphenolic fraction. Antioxidants 8 (3):66. doi: https://doi.org/10.3390/antiox8030066.
- Laforge, M., V. Rodrigues, R. Silvestre, C. Gautier, R. Weil, O. Corti, and J. Estaquier. 2016. NF-κB pathway controls mitochondrial dynamics. Cell Death and Differentiation 23 (1):89–98. doi: https://doi.org/10.1038/cdd.2015.42.
- Lampert, M. A., A. M. Orogo, R. H. Najor, B. C. Hammerling, L. J. Leon, B. J. Wang, T. Kim, M. A. Sussman, and Å. B. Gustafsson. 2019. BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation. Autophagy 15 (7):1182–98. doi: https://doi.org/10.1080/15548627.2019.1580095.
- Latorre-Pellicer, A., R. Moreno-Loshuertos, A. V. Lechuga-Vieco, F. Sánchez-Cabo, C. Torroja, R. Acín-Pérez, E. Calvo, E. Aix, A. González-Guerra, A. Logan, et al. 2016. Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing. Nature 535 (7613):561–5. doi: https://doi.org/10.1038/nature18618.
- Laufs, U., S. Wassmann, T. Czech, T. Münzel, M. Eisenhauer, M. Böhm, and G. Nickenig. 2005. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (4):809–14. doi: https://doi.org/10.1161/01.ATV.0000158311.24443.af.
- Lee, S. J., J. S. Kang, H. M. Kim, E. S. Lee, J. Lee, C. H. Chung, and E. Y. Lee. 2019. CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress. PloS One 14 (9):e0222352. doi: https://doi.org/10.1371/journal.pone.0222352.
- Lee, W. J., K. Song, E. H. Koh, J. C. Won, H. S. Kim, H. Park, M. Kim, S. Kim, K. Lee, and J. Park. 2005. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochemical and Biophysical Research Communications 332 (3):885–91. doi: https://doi.org/10.1016/j.bbrc.2005.05.035.
- Leibowitz, A., A. Volkov, K. Voloshin, C. Shemesh, I. Barshack, and E. Grossman. 2016. Melatonin prevents kidney injury in a high salt diet‐induced hypertension model by decreasing oxidative stress. Journal of Pineal Research 60 (1):48–54. doi: https://doi.org/10.1111/jpi.12287.
- Leo, S., G. Szabadkai, and R. Rizzuto. 2008. The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle. Annals of the New York Academy of Sciences 1147:264–74. doi: https://doi.org/10.1196/annals.1427.019.
- Li, B., W. Cui, Y. Tan, P. Luo, Q. Chen, C. Zhang, W. Qu, L. Miao, and L. Cai. 2014. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. Journal of Cellular and Molecular Medicine 18 (5):895–906. doi: https://doi.org/10.1111/jcmm.12239.
- Li, Z., C. M. Dungan, B. Carrier, T. C. Rideout, and D. L. Williamson. 2014. Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats. Lipids 49 (12):1193–201. doi: https://doi.org/10.1007/s11745-014-3964-x.
- Lihn, A. S., S. B. Pedersen, and B. Richelsen. 2005. Adiponectin: Action, regulation and association to insulin sensitivity. Obesity Reviews 6 (1):13–21. doi: https://doi.org/10.1111/j.1467-789X.2005.00159.x.
- Lim, S., M. A. Rashid, M. Jang, Y. Kim, H. Won, J. Lee, J-t Woo, Y. S. Kim, M. P. Murphy, L. Ali, et al. 2011. Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cellular Physiology and Biochemistry : international Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 28 (5):873–86. doi: https://doi.org/10.1159/000335802.
- Lin, Y., A. H. Berg, P. Iyengar, T. K. T. Lam, A. Giacca, T. P. Combs, M. W. Rajala, X. Du, B. Rollman, W. Li, et al. 2005. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. Journal of Biological Chemistry 280 (6):4617–26. doi: https://doi.org/10.1074/jbc.M411863200.
- Lin, H.-Y., S.-W. Weng, Y.-H. Chang, Y.-J. Su, C.-M. Chang, C.-J. Tsai, F.-C. Shen, J.-H. Chuang, T.-K. Lin, C.-W. Liou, et al. 2018. The causal role of mitochondrial dynamics in regulating insulin resistance in diabetes: Link through mitochondrial reactive oxygen species. Oxidative Medicine and Cellular Longevity 2018:7514383. doi: https://doi.org/10.1155/2018/7514383.
- Liong, S., and M. Lappas. 2015. Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes. PloS One 10 (4):e0122633. doi: https://doi.org/10.1371/journal.pone.0122633.
- Li, R., T. Ren, and J. Zeng. 2019. Mitochondrial coenzyme Q protects sepsis-induced acute lung injury by activating PI3K/Akt/GSK-3β/mTOR pathway in rats. BioMed Research International 2019:5240898. doi: https://doi.org/10.1155/2019/5240898.
- Liu, L., D. Feng, G. Chen, M. Chen, Q. Zheng, P. Song, Q. Ma, C. Zhu, R. Wang, W. Qi, et al. 2012. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nature Cell Biology 14 (2):177–85. doi: https://doi.org/10.1038/ncb2422.
- Liu, R., P. Jin, Y. Wang, L. Han, T. Shi, and X. Li. 2014. Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle. PloS One 9 (3):e92810. doi: https://doi.org/10.1371/journal.pone.0092810.
- Liu, X., X. Xu, Y. Zhang, and J. Ren. 2015. Beclin-1 haploinsufficiency protects against obesity-induced cardiac dysfunction through compensatory mitophagy and alternative autophagy. Circulation 132 (suppl_3):A18792.
- Li, Y., T. Zhou, A. Hsu, P. Edwards, H. Gao, and X. Qiao. 2019. Metformin reduces inflammation in diabetic human vitreous by activating AMPK and inhibiting NFκB signaling pathway. Investigative Ophthalmology & Visual Science 60 (9):6548.
- Luengo, A., L. B. Sullivan, and M. G. Vander Heiden. 2014. Understanding the complex-I-ty of metformin action: Limiting mitochondrial respiration to improve cancer therapy. BMC Biology 12 (1):82–4. doi: https://doi.org/10.1186/s12915-014-0082-4.
- Luo, B., B. Li, W. Wang, X. Liu, Y. Xia, C. Zhang, M. Zhang, Y. Zhang, and F. An. 2014. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PloS One 9 (8):e104771. doi: https://doi.org/10.1371/journal.pone.0104771.
- Luo, Y., P. Yang, Z. Li, Y. Luo, J. Shen, R. Li, H. Zheng, Y. Liang, and N. Xia. 2019. Liraglutide improves non-alcoholic fatty liver disease in diabetic mice by modulating inflammatory signaling pathways. Drug Design, Development and Therapy 13:4065–74. doi: https://doi.org/10.2147/DDDT.S224688.
- Ma, S., J. Feng, R. Zhang, J. Chen, D. Han, X. Li, B. Yang, X. Li, M. Fan, C. Li, et al. 2017. SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxidative Medicine and Cellular Longevity 2017:4602715. doi: https://doi.org/10.1155/2017/4602715.
- Maiese, K. 2015. New insights for oxidative stress and diabetes mellitus. Oxidative Medicine and Cellular Longevity 2015:875961. doi: https://doi.org/10.1155/2015/875961.
- Maiti, A. K., N. C. Saha, S. S. More, A. K. Panigrahi, and G. Paul. 2017. Neuroprotective efficacy of mitochondrial antioxidant MitoQ in suppressing peroxynitrite-mediated mitochondrial dysfunction inflicted by lead toxicity in the rat brain. Neurotoxicity Research 31 (3):358–72. doi: https://doi.org/10.1007/s12640-016-9692-7.
- Maiti, A. K., B. C. Spoorthi, N. C. Saha, and A. K. Panigrahi. 2018. Mitigating peroxynitrite mediated mitochondrial dysfunction in aged rat brain by mitochondria-targeted antioxidant MitoQ. Biogerontology 19 (3–4):271–86. doi: https://doi.org/10.1007/s10522-018-9756-6.
- Malik, S. A., J. D. Acharya, N. K. Mehendale, S. S. Kamat, and S. S. Ghaskadbi. 2019. Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation. Free Radical Research 53 (7):815–27. doi: https://doi.org/10.1080/10715762.2019.1635252.
- Malik, A. N., C. K. Parsade, S. Ajaz, R. Crosby-Nwaobi, L. Gnudi, A. Czajka, and S. Sivaprasad. 2015. Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 110 (3):257–65. doi: https://doi.org/10.1016/j.diabres.2015.10.006.
- Manczak, M., P. Mao, M. J. Calkins, A. Cornea, A. P. Reddy, M. P. Murphy, H. H. Szeto, B. Park, and P. H. Reddy. 2010. Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer’s disease neurons. Journal of Alzheimer's Disease 20 (s2):S609–S31. doi: https://doi.org/10.3233/JAD-2010-100564.
- Mao, P., M. Manczak, U. P. Shirendeb, and P. H. Reddy. 2013. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochimica et Biophysica Acta 1832 (12):2322–31. doi: https://doi.org/10.1016/j.bbadis.2013.09.005.
- Mariappan, N., C. M. Elks, S. Sriramula, A. Guggilam, Z. Liu, O. Borkhsenious, and J. Francis. 2010. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes . Cardiovascular Research 85 (3):473–83. doi: https://doi.org/10.1093/cvr/cvp305.
- Marín-Royo, G., C. Rodríguez, A. Le Pape, R. Jurado-López, M. Luaces, A. Antequera, J. Martínez-González, F. V. Souza-Neto, M. L. Nieto, E. Martínez-Martínez, et al. 2019. The role of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 33 (11):12060–72. doi: https://doi.org/10.1096/fj.201900347RR.
- Matzinger, M., K. Fischhuber, D. Pölöske, K. Mechtler, and E. H. Heiss. 2020. AMPK leads to phosphorylation of the transcription factor Nrf2, tuning transactivation of selected target genes. Redox Biology 29:101393. doi: https://doi.org/10.1016/j.redox.2019.101393.
- Ma, B., Z. Zhu, J. Zhang, C. Ren, and Q. Zhang. 2020. Aucubin alleviates diabetic nephropathy by inhibiting NF-κB activation and inducing SIRT1/SIRT3-FOXO3a signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Journal of Functional Foods 64:103702. doi: https://doi.org/10.1016/j.jff.2019.103702.
- Medina-Luna, D., M. G. Santamaría-Olmedo, Y. Zamudio-Cuevas, K. Martínez-Flores, J. Fernández-Torres, G. A. Martínez-Nava, D. Clavijo-Cornejo, C. Hernández-Díaz, A. Olivos-Meza, L. E. Gomez-Quiroz, et al. 2017. Hyperlipidemic microenvironment conditionates damage mechanisms in human chondrocytes by oxidative stress. Lipids in Health and Disease 16 (1):1–8. doi: https://doi.org/10.1186/s12944-017-0510-x.
- Mercer, J. R., E. Yu, N. Figg, K. Cheng, T. A. Prime, J. L. Griffin, M. Masoodi, A. Vidal-Puig, M. P. Murphy, and M. R. Bennett. 2012. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radical Biology & Medicine 52 (5):841–9. doi: https://doi.org/10.1016/j.freeradbiomed.2011.11.026.
- Mezzano, S., C. Aros, A. Droguett, M. E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega, and J. Egido. 2004. NF-κB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology Dialysis Transplantation 19 (10):2505–12. doi: https://doi.org/10.1093/ndt/gfh207.
- Miyata, T., and C. V. Y. De Strihou. 2010. Diabetic nephropathy: A disorder of oxygen metabolism? Nature Reviews. Nephrology 6 (2):83–95. doi: https://doi.org/10.1038/nrneph.2009.211.
- Mo, C., L. Wang, J. Zhang, S. Numazawa, H. Tang, X. Tang, X. Han, J. Li, M. Yang, Z. Wang, et al. 2014. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxidants & Redox Signaling 20 (4):574–88. doi: https://doi.org/10.1089/ars.2012.5116.
- Mohamed, J. S., A. Hajira, P. S. Pardo, and A. M. Boriek. 2014. MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1α network in skeletal muscle. Diabetes 63 (5):1546–59. doi: https://doi.org/10.2337/db13-1364.
- Moller, D. E. 2000. Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism: TEM 11 (6):212–7. doi: https://doi.org/10.1016/S1043-2760(00)00272-1.
- Moynihan, K. A., A. A. Grimm, M. M. Plueger, E. Bernal-Mizrachi, E. Ford, C. Cras-Méneur, M. A. Permutt, and S. Imai. 2005. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice . Cell Metabolism 2 (2):105–17. doi: https://doi.org/10.1016/j.cmet.2005.07.001.
- Murakami, S., A. Ono, A. Kawasaki, T. Takenaga, and T. Ito. 2018. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids 50 (9):1279–88. doi: https://doi.org/10.1007/s00726-018-2605-8.
- Nannipieri, M., C. Gonzales, S. Baldi, R. Posadas, K. Williams, S. M. Haffner, M. P. Stern, and E. Ferrannini. 2005. Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study. Diabetes Care 28 (7):1757–62. doi: https://doi.org/10.2337/diacare.28.7.1757.
- Nemoto, S., M. M. Fergusson, and T. Finkel. 2005. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. The Journal of Biological Chemistry 280 (16):16456–60. doi: https://doi.org/10.1074/jbc.M501485200.
- Nguyen, T. M. D., Y. Combarnous, C. Praud, A. Duittoz, and E. Blesbois. 2016. Ca2+/calmodulin-dependent protein kinase kinases (CaMKKs) effects on AMP-activated protein kinase (AMPK) regulation of chicken sperm functions. PLoS One 11 (1):e0147559. doi: https://doi.org/10.1371/journal.pone.0147559.
- Nishikawa, T., and E. Araki. 2007. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxidants and Redox Signaling 9 (3):343–53. doi: https://doi.org/10.1089/ars.2006.1458.
- Nisr, R. B., D. S. Shah, I. G. Ganley, and H. S. Hundal. 2019. Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading. Cellular and Molecular Life Sciences: CMLS 76 (24):4887–904. doi: https://doi.org/10.1007/s00018-019-03148-8.
- Odegaard, A. O., D. R. Jacobs, O. A. Sanchez, D. C. Goff, A. P. Reiner, and M. D. Gross. 2016. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovascular Diabetology 15 (1):51. doi: https://doi.org/10.1186/s12933-016-0369-6.
- Oliver, D. M., and P. H. Reddy. 2019. Small molecules as therapeutic drugs for Alzheimer's disease. Molecular and Cellular Neurosciences 96:47–62. doi: https://doi.org/10.1016/j.mcn.2019.03.001.
- Oliver, D., and P. H. Reddy. 2019. Dynamics of Dynamin-related protein 1 in Alzheimer’s disease and other neurodegenerative diseases. Cells 8 (9):961. doi: https://doi.org/10.3390/cells8090961.
- Öst, A., K. Svensson, I. Ruishalme, C. Brännmark, N. Franck, H. Krook, P. Sandström, P. Kjolhede, and P. Strålfors. 2010. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Molecular Medicine (Cambridge, Mass.) 16 (7–8):235–46. doi: https://doi.org/10.2119/molmed.2010.00023.
- Oyewole, A. O., and M. A. Birch-Machin. 2015. Mitochondria-targeted antioxidants. FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology 29 (12):4766–71. doi: https://doi.org/10.1096/fj.15-275404.
- Ozata, M., M. Mergen, C. Oktenli, A. Aydin, S. Y. Sanisoglu, E. Bolu, M. I. Yilmaz, A. Sayal, A. Isimer, and I. C. Ozdemir. 2002. Increased oxidative stress and hypozincemia in male obesity. Clinical Biochemistry 35 (8):627–31. doi: https://doi.org/10.1016/S0009-9120(02)00363-6.
- Pan, K., S. Jiang, X. Du, X. Zeng, J. Zhang, L. Song, J. Zhou, H. Kan, Q. Sun, Y. Xie, et al. 2019. AMPK activation attenuates inflammatory response to reduce ambient PM2.5-induced metabolic disorders in healthy and diabetic mice. Ecotoxicology and Environmental Safety 179:290–300. doi: https://doi.org/10.1016/j.ecoenv.2019.04.038.
- Pandey, K. B., N. Mishra, and S. I. Rizvi. 2010. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clinical Biochemistry 43 (4–5):508–11. doi: https://doi.org/10.1016/j.clinbiochem.2009.11.011.
- Park, J., J. Min, B. Kim, U. Chae, J. W. Yun, M. Choi, I. Kong, K. Chang, and D. Lee. 2015. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neuroscience Letters 584:191–6. doi: https://doi.org/10.1016/j.neulet.2014.10.016.
- Pasupathi, P., V. Chandrasekar, and U. S. Kumar. 2009. Evaluation of oxidative stress, enzymatic and non-enzymatic antioxidants and metabolic thyroid hormone status in patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 3 (3):160–5. doi: https://doi.org/10.1016/j.dsx.2009.07.004.
- Pedersen, M., H. Bruunsgaard, N. Weis, H. W. Hendel, B. U. Andreassen, E. Eldrup, F. Dela, and B. K. Pedersen. 2003. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mechanisms of Ageing and Development 124 (4):495–502. doi: https://doi.org/10.1016/S0047-6374(03)00027-7.
- Peixoto, C. A., W. H. de Oliveira, S. M. Da Racho Araújo, and A. K. S. Nunes. 2017. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration. Experimental Neurology 298 (Pt A):31–41. doi: https://doi.org/10.1016/j.expneurol.2017.08.013.
- Pernicova, I., and M. Korbonits. 2014. Metformin-mode of action and clinical implications for diabetes and cancer. Nature Reviews. Endocrinology 10 (3):143–56. doi: https://doi.org/10.1038/nrendo.2013.256.
- Pitozzi, V., L. Giovannelli, G. Bardini, C. M. Rotella, and P. Dolara. 2003. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: Higher vulnerability of polymorphonuclear leukocytes. Mutation Research 529 (1–2):129–33. doi: https://doi.org/10.1016/S0027-5107(03)00114-3.
- Polak, P., N. Cybulski, J. N. Feige, J. Auwerx, M. A. Rüegg, and M. N. Hall. 2008. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metabolism 8 (5):399–410. doi: https://doi.org/10.1016/j.cmet.2008.09.003.
- Ramalingam, L., K. Menikdiwela, M. LeMieux, J. M. Dufour, G. Kaur, N. Kalupahana, and N. Moustaid-Moussa. 2017. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochimica et Biophysica Acta. Molecular Basis of Disease 1863 (5):1106–14. doi: https://doi.org/10.1016/j.bbadis.2016.07.019.
- Randeria, S. N., G. J. Thomson, T. A. Nell, T. Roberts, and E. Pretorius. 2019. Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovascular Diabetology 18 (1):72. doi: https://doi.org/10.1186/s12933-019-0870-9.
- Ray, P. D., B. Huang, and Y. Tsuji. 2012. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling 24 (5):981–90. doi: https://doi.org/10.1016/j.cellsig.2012.01.008.
- Reddy, P. H. 2006. Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics. Journal of Biomedicine & Biotechnology 2006 (3):31372. doi: https://doi.org/10.1155/JBB/2006/31372.
- Reddy, P. H. 2008. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Medicine 10 (4):291–315. doi: https://doi.org/10.1007/s12017-008-8044-z.
- Reddy, P. H., and D. Oliver. 2019. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in alzheimer’s disease. Cells 8 (5):488. doi: https://doi.org/10.3390/cells8050488.
- Reddy, P. H., T. P. Reddy, M. Manczak, M. J. Calkins, U. Shirendeb, and P. Mao. 2011. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Research Reviews 67 (1–2):103–18. doi: https://doi.org/10.1016/j.brainresrev.2010.11.004.
- Reifsnyder, P. C., K. Flurkey, A. Te, and D. E. Harrison. 2016. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes. Aging 8 (11):3120–30. doi: https://doi.org/10.18632/aging.101117.
- Ribeiro Junior, R. F., E. R. Dabkowski, K. C. Shekar, K. A. O Connell, P. A. Hecker, and M. P. Murphy. 2018. MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload. Free Radical Biology & Medicine 117:18–29. doi: https://doi.org/10.1016/j.freeradbiomed.2018.01.012.
- Roberts, C. K., R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie, and N. D. Vaziri. 2006. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism: Clinical and Experimental 55 (7):928–34. doi: https://doi.org/10.1016/j.metabol.2006.02.022.
- Robertson, R. P. 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. The Journal of Biological Chemistry 279 (41):42351–4. doi: https://doi.org/10.1074/jbc.R400019200.
- Roberts, C. K., and K. K. Sindhu. 2009. Oxidative stress and metabolic syndrome. Life Sciences 84 (21–22):705–12. doi: https://doi.org/10.1016/j.lfs.2009.02.026.
- Rossman, M. J., J. R. Santos-Parker, C. A. C. Steward, N. Z. Bispham, L. M. Cuevas, H. L. Rosenberg, K. A. Woodward, M. Chonchol, R. A. Gioscia-Ryan, M. P. Murphy, et al. 2018. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension 71 (6):1056–63. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.10787.
- Sakaguchi, M., M. Isono, K. Isshiki, T. Sugimoto, D. Koya, and A. Kashiwagi. 2006. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochemical and Biophysical Research Communications 340 (1):296–301. doi: https://doi.org/10.1016/j.bbrc.2005.12.012.
- Sakuraba, H., H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, and S. Yagihashi. 2002. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45 (1):85–96. doi: https://doi.org/10.1007/s125-002-8248-z.
- Salminen, A., J. M. Hyttinen, and K. Kaarniranta. 2011. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: Impact on healthspan and lifespan. Journal of Molecular Medicine (Berlin, Germany) 89 (7):667–76. doi: https://doi.org/10.1007/s00109-011-0748-0.
- Satapati, S., B. Kucejova, J. A. G. Duarte, J. A. Fletcher, L. Reynolds, N. E. Sunny, T. He, L. A. Nair, K. A. Livingston, K. Livingston, et al. 2015. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. The Journal of Clinical Investigation 125 (12):4447–62. doi: https://doi.org/10.1172/JCI82204.
- Scheelbeek, P. F., L. Cornelsen, T. M. Marteau, S. A. Jebb, and R. D. Smith. 2019. Potential impact on prevalence of obesity in the UK of a 20% price increase in high sugar snacks: Modelling study. BMJ 366:14786.
- Schrauwen, P., and M. K. Hesselink. 2004. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53 (6):1412–7. doi: https://doi.org/10.2337/diabetes.53.6.1412.
- Semple, R. K., V. C. Crowley, C. P. Sewter, M. Laudes, C. Christodoulides, R. V. Considine, A. Vidal-Puig, and S. O'Rahilly. 2004. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 28 (1):176–9. doi: https://doi.org/10.1038/sj.ijo.0802482.
- Shahzad, K., F. Bock, M. M. Al-Dabet, I. Gadi, S. Nazir, H. Wang, S. Kohli, S. Ranjan, P. R. Mertens, P. P. Nawroth, et al. 2016. Stabilization of endogenous Nrf2 by minocycline protects against NLRP3-inflammasome induced diabetic nephropathy. Scientific Reports 6 (1):34228–14. doi: https://doi.org/10.1038/srep34228.
- Sharma, B., and R. Dabur. 2020. Role of Pro-inflammatory cytokines in regulation of skeletal muscle metabolism: A systematic review. Current Medicinal Chemistry 27 (13):2161–88. doi: https://doi.org/10.2174/0929867326666181129095309.
- Sharma, P., S. Mishra, P. Ajmera, and S. Mathur. 2005. Oxidative stress in metabolic syndrome. Indian Journal of Clinical Biochemistry 20 (1):145–9. doi: https://doi.org/10.1007/BF02893061.
- Shiota, A., M. Shimabukuro, D. Fukuda, T. Soeki, H. Sato, E. Uematsu, Y. Hirata, H. Kurobe, N. Maeda, H. Sakaue, et al. 2012. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovascular Diabetology 11 (1):139. doi: https://doi.org/10.1186/1475-2840-11-139.
- Singh, S. P., L. Bellner, L. Vanella, J. Cao, J. R. Falck, A. Kappas, and N. G. Abraham. 2016. Downregulation of PGC-1α prevents the beneficial effect of EET-heme oxygenase-1 on mitochondrial integrity and associated metabolic function in obese mice. Journal of Nutrition and Metabolism 2016:1–15. doi: https://doi.org/10.1155/2016/9039754.
- Singh, S. P., J. Schragenheim, J. Cao, J. R. Falck, N. G. Abraham, and L. Bellner. 2016. PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid. Prostaglandins Other Lipid Mediat 125:8–18. doi: https://doi.org/10.1016/j.prostaglandins.2016.07.004.
- Smith, R. A., C. M. Porteous, C. V. Coulter, and M. P. Murphy. 1999. Selective targeting of an antioxidant to mitochondria. European Journal of Biochemistry 263 (3):709–16. doi: https://doi.org/10.1046/j.1432-1327.1999.00543.x.
- Solesio, M. E., T. A. Prime, A. Logan, M. P. Murphy, M. Del Mar Arroyo-Jimenez, J. Jordán, and M. F. Galindo. 2013. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease. Biochimica et Biophysica Acta 1832 (1):174–82. doi: https://doi.org/10.1016/j.bbadis.2012.07.009.
- Suhara, T., Y. Baba, B. K. Shimada, J. K. Higa, and T. Matsui. 2017. The mTOR signaling pathway in myocardial dysfunction in type 2 diabetes mellitus. Current Diabetes Reports 17 (6):38. doi: https://doi.org/10.1007/s11892-017-0865-4.
- Sun, C., X. Liu, C. Di, Z. Wang, X. Mi, Y. Liu, Q. Zhao, A. Mao, W. Chen, L. Gan, et al. 2017. MitoQ regulates autophagy by inducing a pseudo-mitochondrial membrane potential. Autophagy 13 (4):730–8. doi: https://doi.org/10.1080/15548627.2017.1280219.
- Suzuki, D., and T. Miyata. 1999. Carbonyl stress in the pathogenesis of diabetic nephropathy. Internal medicine 38 (4):309–14. doi: https://doi.org/10.2169/internalmedicine.38.309.
- Tan, Y., T. Ichikawa, J. Li, Q. Si, H. Yang, X. Chen, C. S. Goldblatt, C. J. Meyer, X. Li, L. Cai, et al. 2011. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 60 (2):625–33. doi: https://doi.org/10.2337/db10-1164.
- Tang, B. L. 2016. Sirt1 and the mitochondria. Molecules and Cells 39 (2):87–95. doi: https://doi.org/10.14348/molcells.2016.2318.
- Tang, S., Q. Zhang, H. Tang, C. Wang, H. Su, Q. Zhou, W. Wei, H. Zhu, and Y. Wang. 2016. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: Possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways. Endocrine 53 (1):107–16. doi: https://doi.org/10.1007/s12020-015-0852-y.
- Tauskela, J. S. 2007. MitoQ-a mitochondria-targeted antioxidant. IDrugs : The Investigational Drugs Journal 10 (6):399–412.
- Teng, W., L. Zhao, S. Yang, C. Zhang, M. Liu, J. Luo, J. Jin, M. Zhang, C. Bao, D. Li, et al. 2019. The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. Journal of Controlled Release: Official Journal of the Controlled Release Society 307:139–49. doi: https://doi.org/10.1016/j.jconrel.2019.06.023.
- Tiwari, B. K., K. B. Pandey, A. B. Abidi, and S. I. Rizvi. 2013. Markers of oxidative stress during diabetes mellitus. Journal of Biomarkers 2013:378790. doi: https://doi.org/10.1155/2013/378790.
- Tomé-Carneiro, J., M. Larrosa, A. González-Sarrías, F. A. Tomas-Barberan, M. Teresa Garcia-Conesa, and J. Carlos Espin. 2013. Resveratrol and clinical trials: The crossroad from in vitro studies to human evidence. Current Pharmaceutical Design 19 (34):6064–93. doi: https://doi.org/10.2174/13816128113199990407.
- Tong, M., T. Saito, P. Zhai, S. Oka, W. Mizushima, M. Nakamura, S. Ikeda, A. Shirakabe, and J. Sadoshima. 2019. Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy. Circulation Research 124 (9):1360–71. doi: https://doi.org/10.1161/CIRCRESAHA.118.314607.
- Toyoda, K., A. Nakano, Y. Fujibayashi, Y. Yonekura, T. Ueda, and J. Lee. 2007. Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction. International Journal of Cardiology 115 (3):297–304. doi: https://doi.org/10.1016/j.ijcard.2006.03.012.
- Tschopp, J. 2011. Mitochondria: Sovereign of inflammation? European Journal of Immunology 41 (5):1196–202. doi: https://doi.org/10.1002/eji.201141436.
- Vainshtein, A., L. D. Tryon, M. Pauly, and D. A. Hood. 2015. Role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle. American Journal of Physiology. Cell Physiology 308 (9):C710–9. doi: https://doi.org/10.1152/ajpcell.00380.2014.
- Van Houten, B., V. Woshner, and J. H. Santos. 2006. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 5 (2):145–52. doi: https://doi.org/10.1016/j.dnarep.2005.03.002.
- Vergoni, B., P.-J. Cornejo, J. Gilleron, M. Djedaini, F. Ceppo, A. Jacquel, G. Bouget, C. Ginet, T. Gonzalez, J. Maillet, et al. 2016. DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes. Diabetes 65 (10):3062–74. doi: https://doi.org/10.2337/db16-0014.
- Virtue, S., and A. Vidal-Puig. 2010. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochimica et Biophysica Acta 1801 (3):338–49. doi: https://doi.org/10.1016/j.bbalip.2009.12.006.
- Völkers, M., S. Doroudgar, N. Nguyen, M. H. Konstandin, P. Quijada, S. Din, L. Ornelas, D. J. Thuerauf, N. Gude, K. Friedrich, et al. 2014. PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity. EMBO Molecular Medicine 6 (1):57–65. doi: https://doi.org/10.1002/emmm.201303183.
- Vringer, E., and S. W. Tait. 2019. Mitochondria and inflammation: Cell death heats up. Frontiers in Cell and Developmental Biology 7:100. doi: https://doi.org/10.3389/fcell.2019.00100.
- Wang, X., H. Gao, W. Wu, E. Xie, Y. Yu, X. He, J. Li, W. Zheng, X. Wang, X. Cao, et al. 2019. The zinc transporter Slc39a5 controls glucose sensing and insulin secretion in pancreatic β-cells via Sirt1- and Pgc-1α-mediated regulation of Glut2. Protein Cell 10 (6):436–49. doi: https://doi.org/10.1007/s13238-018-0580-1.
- Wang, L., T. Ishihara, Y. Ibayashi, K. Tatsushima, D. Setoyama, Y. Hanada, Y. Takeichi, S. Sakamoto, S. Yokota, K. Mihara, et al. 2015. Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration. Diabetologia 58 (10):2371–80. doi: https://doi.org/10.1007/s00125-015-3704-7.
- Wannamethee, S. G., A. G. Shaper, L. Lennon, and P. H. Whincup. 2005. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28 (12):2913–8. doi: https://doi.org/10.2337/diacare.28.12.2913.
- Ward, M. S., N. B. Flemming, L. A. Gallo, A. K. Fotheringham, D. A. McCarthy, A. Zhuang, P. H. Tang, D. J. Borg, H. Shaw, B. Harvie, et al. 2017. Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. Scientific Reports 7 (1):15190. doi: https://doi.org/10.1038/s41598-017-15589-x.
- Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante. 2003. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112 (12):1796–808. doi: https://doi.org/10.1172/JCI200319246.
- Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. Journal of Clinical Investigation 115 (5):1111–9. doi: https://doi.org/10.1172/JCI25102.
- Wenzel, P., S. Schuhmacher, J. Kienhöfer, J. Müller, M. Hortmann, M. Oelze, E. Schulz, N. Treiber, T. Kawamoto, K. Scharffetter-Kochanek, et al. 2008. Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovascular Research 80 (2):280–9. doi: https://doi.org/10.1093/cvr/cvn182.
- Whaley-Connell, A., P. A. McCullough, and J. R. Sowers. 2019. The role of oxidative stress in the metabolic syndrome. Reviews in Cardiovascular Medicine 12 (1):21–9.
- Wu, H., L. Kong, Y. Cheng, Z. Zhang, Y. Wang, M. Luo, Y. Tan, X. Chen, L. Miao, and L. Cai. 2015. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2. Free Radical Biology and Medicine 89:431–42. doi: https://doi.org/10.1016/j.freeradbiomed.2015.08.009.
- Wu, W., C. Lin, K. Wu, L. Jiang, X. Wang, W. Li, H. Zhuang, X. Zhang, H. Chen, S. Li, et al. 2016. FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions. The EMBO Journal 35 (13):1368–84. doi: https://doi.org/10.15252/embj.201593102.
- Wu, H., Y. Wang, W. Li, H. Chen, L. Du, D. Liu, X. Wang, T. Xu, L. Liu, and Q. Chen. 2019. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome. Autophagy 15 (11):1882–98. doi: https://doi.org/10.1080/15548627.2019.1596482.
- Wu, W., H. Xu, Z. Wang, Y. Mao, L. Yuan, W. Luo, Z. Cui, T. Cui, X. L. Wang, and Y. H. Shen. 2015. PINK1-Parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury. PloS One 10 (7):e0132499. doi: https://doi.org/10.1371/journal.pone.0132499.
- Xi, Y., D. Feng, K. Tao, R. Wang, Y. Shi, H. Qin, M. P. Murphy, Q. Yang, and G. Zhao. 2018. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864 (9 Pt B):2859–70. doi: https://doi.org/10.1016/j.bbadis.2018.05.018.
- Xiao, L., X. Xu, F. Zhang, M. Wang, Y. Xu, D. Tang, J. Wang, Y. Qin, Y. Liu, C. Tang, et al. 2017. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biology 11:297–311. doi: https://doi.org/10.1016/j.redox.2016.12.022.
- Xie, Z., L. Zhong, Y. Wu, X. Wan, H. Yang, X. Xu, and P. Li. 2018. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 47:161–73. doi: https://doi.org/10.1016/j.phymed.2018.04.031.
- Xu, X. J., R. J. Valentine, and N. B. Ruderman. 2014. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity? Current Obesity Reports 3 (2):248–55. doi: https://doi.org/10.1007/s13679-014-0095-x.
- Yakes, F. M., and B. Van Houten. 1997. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 94 (2):514–9. doi: https://doi.org/10.1073/pnas.94.2.514.
- Yan, M., Y. Li, M. Meng, H. Ren, and Y. Kou. 2006. Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia. Biochemical and Biophysical Research Communications 347 (1):192–9. doi: https://doi.org/10.1016/j.bbrc.2006.06.063.
- Yang, H., A. Feng, S. Lin, L. Yu, X. Lin, X. Yan, X. Lu, and C. Zhang. 2018. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Cell Death & Disease 9 (2):1–14. doi: https://doi.org/10.1038/s41419-018-0307-5.
- Yang, X., T. Liu, B. Chen, F. Wang, Q. Yang, and X. Chen. 2017. Grape seed proanthocyanidins prevent irradiation-induced differentiation of human lung fibroblasts by ameliorating mitochondrial dysfunction. Scientific Reports 7 (1):62. doi: https://doi.org/10.1038/s41598-017-00108-9.
- Yang, J., V. A. M. Villar, P. A. Jose, and C. Zeng. 2020. Renal dopamine receptors and oxidative stress: role in hypertension. Antioxidants & Redox Signaling.doi: https://doi.org/10.1089/ars.2020.8106.
- Yang, L., J. Wei, F. Sheng, and P. Li. 2019. Attenuation of palmitic acid–induced lipotoxicity by chlorogenic acid through activation of SIRT1 in hepatocytes. Molecular Nutrition & Food Research 63 (14):1801432. doi: https://doi.org/10.1002/mnfr.201801432.
- Yau, W. W., B. K. Singh, R. Lesmana, J. Zhou, R. A. Sinha, K. A. Wong, Y. Wu, B.-H. Bay, S. Sugii, L. Sun, et al. 2019. Thyroid hormone (T3) stimulates brown adipose tissue activation via mitochondrial biogenesis and MTOR-mediated mitophagy. Autophagy 15 (1):131–50. doi: https://doi.org/10.1080/15548627.2018.1511263.
- Yin, X., M. Manczak, and P. H. Reddy. 2016. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease. Human Molecular Genetics 25 (9):1739–53. doi: https://doi.org/10.1093/hmg/ddw045.
- Zhang, W., S. Siraj, R. Zhang, and Q. Chen. 2017. Mitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I/R injury. Autophagy 13 (6):1080–1. doi: https://doi.org/10.1080/15548627.2017.1300224.
- Zhang, T., P. Wu, E. Budbazar, Q. Zhu, C. Sun, J. Mo, J. Peng, V. Gospodarev, J. Tang, H. Shi, et al. 2019. Mitophagy reduces oxidative stress via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) pathway after subarachnoid hemorrhage in rats. Stroke 50 (4):978–88. doi: https://doi.org/10.1161/STROKEAHA.118.021590.
- Zhang, Y., X. Xu, and J. Ren. 2013. MTOR overactivation and interrupted autophagy flux in obese hearts: A dicey assembly? Autophagy 9 (6):939–41. doi: https://doi.org/10.4161/auto.24398.
- Zhang, B. B., G. Zhou, and C. Li. 2009. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metabolism 9 (5):407–16. doi: https://doi.org/10.1016/j.cmet.2009.03.012.
- Zhao, M., X. W. Li, D. Z. Chen, F. Hao, S. X. Tao, H. Y. Yu, R. Cheng, and H. Liu. 2019. Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Medical Science Monitor 25:2186–94. doi: https://doi.org/10.12659/MSM.911250.
- Zhao, D., J. Yang, and L. Yang. 2017. Insights for oxidative stress and mTOR signaling in myocardial ischemia/reperfusion injury under diabetes. Oxidative Medicine and Cellular Longevity 2017:6437467. doi: https://doi.org/10.1155/2017/6437467.
- Zheng, W., J. Zhou, S. Song, W. Kong, W. Xia, L. Chen, and T. Zeng. 2018. Dipeptidyl-peptidase 4 inhibitor sitagliptin ameliorates hepatic insulin resistance by modulating inflammation and autophagy in ob/ob mice. International Journal of Endocrinology 2018:8309723. doi: https://doi.org/10.1155/2018/8309723.
- Zhou, B., Q. Guo, L. I. Huixia, X. U. Lin, and L. I. Hongxia. 2017. Fibroblast growth factor 21 improves insulin resistance via inhibiting hepatic oxidative stress in obese mice. Journal of Xi'an Jiaotong University (Medical Sciences) 38 (2):161–5, 87.
- Zhou, H., and S. Toan. 2020. Pathological roles of mitochondrial oxidative stress and mitochondrial dynamics in cardiac microvascular ischemia/reperfusion injury. Biomolecules 10 (1):85. doi: https://doi.org/10.3390/biom10010085.
- Zhou, W., and S. Ye. 2018. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy. Cell Biology International 42 (10):1282–91. doi: https://doi.org/10.1002/cbin.11015.
- Zoncu, R., A. Efeyan, and D. M. Sabatini. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nature Reviews. Molecular Cell Biology 12 (1):21–35. doi: https://doi.org/10.1038/nrm3025.
- Zorzano, A. 2009. Regulation of mitofusin-2 expression in skeletal muscle. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme 34 (3):433–9. doi: https://doi.org/10.1139/H09-049.
- Zorzano, A., M. Liesa, and M. Palacín. 2009. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. The International Journal of Biochemistry & Cell Biology 41 (10):1846–54. doi: https://doi.org/10.1016/j.biocel.2009.02.004.
- Zozina, V. I., S. Covantev, O. A. Goroshko, L. M. Krasnykh, and V. G. Kukes. 2018. Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem. Current Cardiology Reviews 14 (3):164–74. doi: https://doi.org/10.2174/1573403X14666180416115428.